Patient and Parent Preferences for an On-Body Automated Insulin Delivery System

Type 1 diabetes remains the most common chronic disease of childhood and affects millions of
children and adults globally. The minority of persons with type 1 diabetes achieve the
recommended glycemic targets. Currently approved and unapproved automated insulin delivery
systems require patients to carry and wear multiple devices (pumps, tubing, blood glucose
meters, mobile devices, etc.). There is a need to design automated insulin delivery systems
that reduce the burden of diabetes management for young persons and their families in an
effort to improve glycemic control as well as other biomedical and psychosocial outcomes.

The purpose of this study is to conduct separate semi-structured interviews with young
persons with type 1 diabetes and parents of youth with type 1 diabetes (not necessarily the
parents of the youth participants) regarding their preferences for an automated, on-body
insulin delivery system. Youth and parents will also complete short surveys related to
perceived burden of diabetes self-care, quality of life, acceptance of diabetes, and worries
about hypoglycemia. The feedback received from the interviews and surveys will help inform
the design of a new on-body automated insulin delivery system.

Inclusion Criteria:

- Young persons (ages 8-25 years) with type 1 diabetes for 1 year or longer

- Parents of young persons with type 1 diabetes

Exclusion Criteria: